Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06604091

Cohort Profile:The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)

Sponsor: The Second Hospital of Shandong University

View on ClinicalTrials.gov

Summary

Previous studies have shown that compared with infertile women without adenomyosis, the clinical pregnancy rate, live birth rate and continuous pregnancy rate of women with adenomyosis significantly reduce, and the abortion rate obviously increased. However, these studies lack a definite classification of adenomyosis, so the true effect of adenomyosis with different severity on pregnancy outcomes are not clear. Our research team intends to collect clinical data of infertility patients with adenomyosis receiving IVF and the detailed classification of adenomyosis according to MUSA criteria. Finally, we can have an objective recognition of adenomyosis on pregnancy outcomes, which also bring benefits to evidence-based clinical practice.

Key Details

Gender

FEMALE

Age Range

20 Years - 37 Years

Study Type

OBSERVATIONAL

Enrollment

2241

Start Date

2024-06-30

Completion Date

2030-01-01

Last Updated

2025-08-21

Healthy Volunteers

No

Interventions

OTHER

Treatment protocol

Treatment options for ovarian stimulation include long-acting and antagonist regimens and other ovulation induction regimens. Options for frozen embryo transfer include natural protocols, mild ovarian stimulation regimens, hormone replacement therapy (HRT) regimens, and down-regulated combined HRT regimens. The treatment regimen is refined in the above protocol. The treatment of patients follows the principles of real-world clinical practice.

Locations (1)

The Second Clinical Hospital of Shandong University

Jinan, Shandong, China